RCP induces Slug expression and cancer cell invasion by stabilizing β1 integrin

Area of Science:

• Oncology
• Cell Biology
• Molecular Biology

Background:

• Rab coupling protein (RCP) is implicated in tumor pathophysiology and patient outcomes.
• Tumor cell migration is a critical process in cancer progression.

Purpose of the Study:

• To elucidate the mechanism by which RCP influences cancer cell aggressiveness.
• To investigate the role of β1 integrin and downstream signaling pathways in RCP-mediated effects.

Main Methods:

• Studied the effect of RCP expression on β1 integrin levels and activation.
• Investigated the induction of Slug, epithelial-to-mesenchymal transition, and invasion.
• Utilized gene silencing, ectopic expression, and pharmacological inhibitors (ILK, EGFR, NF-κB) and dominant-negative Ras (RasN17).
• Assessed lung metastasis in vivo following ectopic RCP expression.

Main Results:

• RCP stabilizes β1 integrin, increasing its levels and activating a signaling cascade.
• RCP induces Slug expression, epithelial-to-mesenchymal transition, and enhances cancer cell invasion.
• Silencing β1 integrin or inhibiting ILK, EGFR, NF-κB, or Ras blocked RCP-induced Slug expression and invasion.
• Ectopic RCP expression promoted ovarian cancer cell metastasis to the lung.

Conclusions:

• RCP promotes cancer cell aggressiveness via β1 integrin stabilization.
• A signaling cascade involving ILK/EGFR/Ras/NF-κB is activated by RCP, leading to Slug induction.
• RCP enhances tumor cell invasion and metastasis, highlighting its role in cancer progression.